1 dataset found
  1. w

    Global Gastrointestinal Stromal Tumor (GIST) Market Research Report: By...

    • wiseguyreports.com
    Updated Oct 14, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    (2025). Global Gastrointestinal Stromal Tumor (GIST) Market Research Report: By Treatment Type (Surgery, Targeted Therapy, Chemotherapy, Radiation Therapy), By Diagnosis Method (Imaging Techniques, Biopsy, Molecular Testing), By Stage of Tumor (Localized, Metastatic), By Patient Demographics (Adults, Children), By Care Setting (Hospital, Outpatient Clinic, Research Center) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/gastrointestinal-stromal-tumor-gist-market
    Explore at:
    Dataset updated
    Oct 14, 2025
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    Oct 25, 2025
    Area covered
    Global
    Description
    BASE YEAR2024
    HISTORICAL DATA2019 - 2023
    REGIONS COVEREDNorth America, Europe, APAC, South America, MEA
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    MARKET SIZE 20243.36(USD Billion)
    MARKET SIZE 20253.48(USD Billion)
    MARKET SIZE 20355.0(USD Billion)
    SEGMENTS COVEREDTreatment Type, Diagnosis Method, Stage of Tumor, Patient Demographics, Care Setting, Regional
    COUNTRIES COVEREDUS, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
    KEY MARKET DYNAMICSrising prevalence of GIST, increasing research funding, advancements in targeted therapies, growing awareness and diagnosis, improved healthcare infrastructure
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDGenesisCare, Novartis, Boehringer Ingelheim, Sobi, Pfizer, Bristol Myers Squibb, Zymeworks, BristolMyers Squibb, Amgen, Eisai, Bayer, Merck, Beigene, Regeneron Pharmaceuticals
    MARKET FORECAST PERIOD2025 - 2035
    KEY MARKET OPPORTUNITIESIncreasing prevalence of GIST cases, Advancements in targeted therapies, Rising demand for personalized medicine, Growing clinical trial activities, Expanding diagnostic technologies for GIST
    COMPOUND ANNUAL GROWTH RATE (CAGR) 3.7% (2025 - 2035)

  2. Not seeing a result you expected?
    Learn how you can add new datasets to our index.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
(2025). Global Gastrointestinal Stromal Tumor (GIST) Market Research Report: By Treatment Type (Surgery, Targeted Therapy, Chemotherapy, Radiation Therapy), By Diagnosis Method (Imaging Techniques, Biopsy, Molecular Testing), By Stage of Tumor (Localized, Metastatic), By Patient Demographics (Adults, Children), By Care Setting (Hospital, Outpatient Clinic, Research Center) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/gastrointestinal-stromal-tumor-gist-market

Global Gastrointestinal Stromal Tumor (GIST) Market Research Report: By Treatment Type (Surgery, Targeted Therapy, Chemotherapy, Radiation Therapy), By Diagnosis Method (Imaging Techniques, Biopsy, Molecular Testing), By Stage of Tumor (Localized, Metastatic), By Patient Demographics (Adults, Children), By Care Setting (Hospital, Outpatient Clinic, Research Center) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Explore at:
Dataset updated
Oct 14, 2025
License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered
Oct 25, 2025
Area covered
Global
Description
BASE YEAR2024
HISTORICAL DATA2019 - 2023
REGIONS COVEREDNorth America, Europe, APAC, South America, MEA
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 20243.36(USD Billion)
MARKET SIZE 20253.48(USD Billion)
MARKET SIZE 20355.0(USD Billion)
SEGMENTS COVEREDTreatment Type, Diagnosis Method, Stage of Tumor, Patient Demographics, Care Setting, Regional
COUNTRIES COVEREDUS, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICSrising prevalence of GIST, increasing research funding, advancements in targeted therapies, growing awareness and diagnosis, improved healthcare infrastructure
MARKET FORECAST UNITSUSD Billion
KEY COMPANIES PROFILEDGenesisCare, Novartis, Boehringer Ingelheim, Sobi, Pfizer, Bristol Myers Squibb, Zymeworks, BristolMyers Squibb, Amgen, Eisai, Bayer, Merck, Beigene, Regeneron Pharmaceuticals
MARKET FORECAST PERIOD2025 - 2035
KEY MARKET OPPORTUNITIESIncreasing prevalence of GIST cases, Advancements in targeted therapies, Rising demand for personalized medicine, Growing clinical trial activities, Expanding diagnostic technologies for GIST
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.7% (2025 - 2035)
Search
Clear search
Close search
Google apps
Main menu